fda warning letter hims compounded semaglutide september 2025 Telehealth booms on surging GLP-1 demand despite safety concerns FDA Issues Warning Letters to

How GLP-1 drugs are reshaping what we eat and why it could matter for the planet You've probably heard of Ozempic or Wegovy by now

Parasitic Nematode Infection Reduces Appetite/Food Intake The GI tract is the largest endocrine organ in the body

Impaired MQC resulting from reduced mitochondrial biogenesis (decreased PGC-1) and mitophagy (impaired PINK1/Parkin pathway) leads to oxidative stress and free fatty acid buildup in hepatocytes

No receptor fatigue was observed

The entry-level option starts at about $199 per month, which covers compounded medications for patients beginning treatment

The FDA granted the application a Priority Review designation, and the drug also received a Commissioner National Priority Voucher, which could further accelerate the review process